BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36670097)

  • 21. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1.
    Li M; Liao H; Wu J; Chen B; Pang R; Huang J; Zhu Y
    Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
    Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
    J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing
    Zhu Q; Ren H; Li X; Qian B; Fan S; Hu F; Xu L; Zhai B
    Aging (Albany NY); 2020 Nov; 12(22):22975-23003. PubMed ID: 33203790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation.
    Sun Y; Ren D; Yang C; Yang W; Zhao J; Zhou Y; Jin X; Wu H
    Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166213. PubMed ID: 34311082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway.
    Huang Y; Fan X; Tao R; Song Q; Wang L; Zhang H; Kong H; Huang J
    J Cell Physiol; 2018 Oct; 233(10):6693-6704. PubMed ID: 29323718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Y-box binding protein 1 augments sorafenib resistance
    Liu T; Xie XL; Zhou X; Chen SX; Wang YJ; Shi LP; Chen SJ; Wang YJ; Wang SL; Zhang JN; Dou SY; Jiang XY; Cui RL; Jiang HQ
    World J Gastroenterol; 2021 Jul; 27(28):4667-4686. PubMed ID: 34366628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma
    Xiao Q; Liu H; Wang HS; Cao MT; Meng XJ; Xiang YL; Zhang YQ; Shu F; Zhang QG; Shan H; Jiang GM
    Theranostics; 2020; 10(22):10245-10261. PubMed ID: 32929346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma.
    Wu J; Chai H; Li F; Ren Q; Gu Y
    Life Sci; 2020 Nov; 260():118406. PubMed ID: 32918976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.
    Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J
    Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism.
    Chiu AP; Tschida BR; Sham TT; Lo LH; Moriarity BS; Li XX; Lo RC; Hinton DE; Rowlands DK; Chan CO; Mok DKW; Largaespada DA; Warner N; Keng VW
    Mol Cancer Res; 2019 Jul; 17(7):1582-1593. PubMed ID: 30975706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
    Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
    J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aquaporin 9 inhibits hepatocellular carcinoma through up-regulating FOXO1 expression.
    Li CF; Zhang WG; Liu M; Qiu LW; Chen XF; Lv L; Mei ZC
    Oncotarget; 2016 Jul; 7(28):44161-44170. PubMed ID: 27329843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
    Liu B; Fang X; Kwong DL; Zhang Y; Verhoeft K; Gong L; Zhang B; Chen J; Yu Q; Luo J; Tang Y; Huang T; Ling F; Fu L; Yan Q; Guan XY
    J Exp Clin Cancer Res; 2022 May; 41(1):182. PubMed ID: 35610614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
    Wang Q; Yang X; Zhou X; Wu B; Zhu D; Jia W; Chu J; Wang J; Wu J; Kong L
    Biochem Biophys Res Commun; 2020 Jun; 526(4):889-897. PubMed ID: 32279994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of microRNA‑300 induces the proliferation of liver cancer by downregulating transcription factor FOXO1.
    Chang Y; Zhou C; Fan L; Qiu G; Wang G; Wei G; Chang X; Li X
    Oncol Rep; 2018 Dec; 40(6):3561-3572. PubMed ID: 30272296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HCV core protein-induced upregulation of microRNA-196a promotes aberrant proliferation in hepatocellular carcinoma by targeting FOXO1.
    Xu H; Li G; Yue Z; Li C
    Mol Med Rep; 2016 Jun; 13(6):5223-9. PubMed ID: 27108614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway.
    Liang M; Wang L; Sun Z; Chen X; Wang H; Qin L; Zhao W; Geng B
    Cell Commun Signal; 2022 May; 20(1):62. PubMed ID: 35534896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of the 14-3-3σ is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway.
    Shao Z; Cai Y; Xu L; Yao X; Shi J; Zhang F; Luo Y; Zheng K; Liu J; Deng F; Li R; Zhang L; Wang H; Li M; Ding Y; Zhao L
    Sci Rep; 2016 May; 6():25631. PubMed ID: 27156963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.